P. Armitage, Statistical methods in medical research, Blackwell Scientific Publications, pp.279-301, 1980.

C. Barberis, B. Mouillac, and T. Durroux, Structural bases of vasopressin/oxytocin receptor function, Journal of Endocrinology, vol.156, issue.2, pp.223-229, 1998.
DOI : 10.1677/joe.0.1560223

M. Birnbaumer, Vasopressin Receptors, Trends in Endocrinology & Metabolism, vol.11, issue.10, pp.406-410, 2000.
DOI : 10.1016/S1043-2760(00)00304-0

A. Borycki, J. Lenormund, M. Guillier, and S. A. Leibovitch, Isolation and characterization of a cDNA clone encoding for rat CSF-1 gene. Post-transcriptional repression occurs in myogenic differentiation, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1174, issue.2, pp.143-152, 1993.
DOI : 10.1016/0167-4781(93)90108-P

A. G. Borycki, M. Guillier, M. P. Leibovitch, and S. A. Leibovitch, Molecular Cloning of CSF-1 Receptor from Rat Myoblasts. Sequence Analysis and Regulation During Myogenesis, Growth Factors, vol.56, issue.4, pp.209-218, 1992.
DOI : 10.3109/08977199209021534

A. G. Borycki, F. Smadja, R. Stanley, and S. A. Leibovitch, Colony-Stimulating Factor 1 (CSF-1)Is Involved in an Autocrine Growth Control of Rat Myogenic Cells, Experimental Cell Research, vol.218, issue.1, pp.213-222, 1995.
DOI : 10.1006/excr.1995.1149

M. Breil and P. Chariot, Muscle disorders associated with cyclosporine treatment, Muscle & Nerve, vol.1241, issue.12, pp.1631-1636, 1999.
DOI : 10.1002/(SICI)1097-4598(199912)22:12<1631::AID-MUS3>3.0.CO;2-V

C. Breton, C. Haenggeli, C. Barberis, F. Heitz, C. R. Bader et al., Presence of Functional Oxytocin Receptors in Cultured Human Myoblasts, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.3, pp.1415-1418, 2002.
DOI : 10.1210/jcem.87.3.8537

C. Cheadle, J. Fan, Y. S. Cho-chung, T. Werner, J. Ray et al., Stability Regulation of mRNA and the Control of Gene Expression, Annals of the New York Academy of Sciences, vol.1058, issue.1, pp.196-204, 2005.
DOI : 10.1196/annals.1359.026

Y. Cheng and W. H. Prusoff, Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction, Biochem Pharmacol, vol.22, pp.3099-3108, 1973.

F. V. Cottet-maire, P. Avdonin, E. Roulet, T. M. Buetler, N. Mermod et al., receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment, British Journal of Pharmacology, vol.117, issue.Suppl 11, pp.909-917, 2001.
DOI : 10.1038/sj.bjp.0703878

J. Deschenes-furry, G. Belanger, J. Mwanjewe, J. A. Lunde, R. J. Parks et al., The RNA-binding Protein HuR Binds to Acetylcholinesterase Transcripts and Regulates Their Expression in Differentiating Skeletal Muscle Cells, Journal of Biological Chemistry, vol.280, issue.27, pp.25361-25368, 2005.
DOI : 10.1074/jbc.M410929200

A. Figueroa, A. Cuadrado, J. Fan, U. Atasoy, G. E. Muscat et al., Role of HuR in Skeletal Myogenesis through Coordinate Regulation of Muscle Differentiation Genes, Molecular and Cellular Biology, vol.23, issue.14, pp.4991-5004, 2003.
DOI : 10.1128/MCB.23.14.4991-5004.2003

B. Fioretti, T. Pietrangelo, L. Catacuzzeno, and F. Franciolini, Intermediate-conductance Ca2+-activated K+ channel is expressed in C2C12 myoblasts and is downregulated during myogenesis, AJP: Cell Physiology, vol.289, issue.1, pp.89-96, 2005.
DOI : 10.1152/ajpcell.00369.2004

Y. Furukawa, N. Hashimoto, T. Yamakuni, Y. Ishida, C. Kato et al., Down-regulation of an ankyrin repeat-containing protein, V-1, during skeletal muscle differentiation and its re-expression in the regenerative process of muscular dystrophy, Neuromuscular Disorders, vol.13, issue.1, pp.32-41, 2003.
DOI : 10.1016/S0960-8966(02)00185-2

J. Howl, X. Wang, C. J. Kirk, and M. Wheatley, Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor, European Journal of Biochemistry, vol.171, issue.2, pp.711-719, 1993.
DOI : 10.1016/0006-8993(88)91437-0

R. W. Jackman and S. C. Kandarian, The molecular basis of skeletal muscle atrophy, AJP: Cell Physiology, vol.287, issue.4, pp.834-843, 2004.
DOI : 10.1152/ajpcell.00579.2003

H. Komati, F. Naro, S. Mebarek, V. De-arcangelis, S. Adamo et al., Phospholipase D Is Involved in Myogenic Differentiation through Remodeling of Actin Cytoskeleton, Molecular Biology of the Cell, vol.16, issue.3, pp.1232-1244, 2005.
DOI : 10.1091/mbc.E04-06-0459

A. Krauskopf, P. Lhote, M. Mutter, J. F. Dufour, U. T. Ruegg et al., Vasopressin type 1A receptor upregulation by cyclosporin A in vascular smooth muscle cells is mediated by superoxide, J Biol Chem, vol.278, pp.1685-41690, 2003.

M. H. Kryszke, V. Moura-neto, A. Lilienbaum, D. Paulin, and C. Auclair, Involvement of histone H4 gene transcription factor 1 in downregulation of vimentin gene expression during skeletal muscle differentiation, FEBS Letters, vol.7, issue.1-2, pp.30-34, 2001.
DOI : 10.1016/S0014-5793(01)02142-1

C. Kusui, T. Kimura, K. Ogita, H. Nakamura, Y. Matsumura et al., DNA Methylation of the Human Oxytocin Receptor Gene Promoter Regulates Tissue-Specific Gene Suppression, Biochemical and Biophysical Research Communications, vol.289, issue.3, pp.681-686, 2001.
DOI : 10.1006/bbrc.2001.6024

S. Minotti, B. M. Scicchitano, C. Nervi, S. Scarpa, M. Lucarelli et al., Vasopressin and insulin-like growth factors synergistically induce myogenesis in serum-free medium, Cell Growth Diff, vol.9, pp.155-163, 1998.

A. Morel, A. O-'carrol, M. J. Brownstein, and S. J. Lolait, Molecular cloning and expression of a rat Via arginine vasopressin receptor, Nature, vol.356, issue.6369, pp.523-526, 1992.
DOI : 10.1038/356523a0

S. Murasawa, H. Matsubara, K. Kizima, K. Maruyama, Y. Mori et al., Glucocorticoids Regulate V1a Vasopressin Receptor Expression by Increasing mRNA Stability in Vascular Smooth Muscle Cells, Hypertension, vol.26, issue.4, pp.665-669, 1995.
DOI : 10.1161/01.HYP.26.4.665

F. Naro, V. De-arcangelis, C. Sette, C. Ambrosio, H. Komati et al., A Bimodal Modulation of the cAMP Pathway Is Involved in the Control of Myogenic Differentiation in L6 Cells, Journal of Biological Chemistry, vol.278, issue.49, pp.49308-49315, 2003.
DOI : 10.1074/jbc.M306941200

F. Naro, V. Donchenko, S. Minotti, L. Zolla, M. Molinaro et al., Role of phospholipase C and D signalling pathways in vasopressin-dependent myogenic differentiation, Journal of Cellular Physiology, vol.61, issue.1, pp.34-42, 1997.
DOI : 10.1002/(SICI)1097-4652(199704)171:1<34::AID-JCP5>3.0.CO;2-I

F. Naro, E. Vicini, C. Sette, M. Grange, A. F. Prigent et al., Phosphatidic acid-dependent activation of adenosine-3???,5???-cyclic-monophosphate-phosphodiesterase is necessary for arg-vasopressin induction of myogenesis, Lipids, vol.51, issue.S1, pp.81-82, 1999.
DOI : 10.1007/BF02562238

C. Nervi, L. Benedetti, A. Minasi, M. Molinaro, and S. Adamo, Arginine-vasopressin induces differentiation of skeletal myogenic cells and upregulation of myogenin and myf-5, Cell Growth Diff, vol.6, pp.81-89, 1995.

N. L. Ostrowski, J. L. Stephen, D. J. Bradley, A. O-'carrol, M. J. Brownstein et al., Distribution of V1a and V2 vasopressin receptor mRNA in rat liver, kidney, pituitary and brain, Endocrinology, vol.131, pp.533-535, 1992.

R. L. Perry and M. A. Rudnick, Molecular mechanisms regulating myogenic determination and differentiation, Frontiers in Bioscience, vol.5, issue.3, pp.750-767, 2000.
DOI : 10.2741/A548

P. Richard, F. Moos, and M. J. Freund-mercier, Central effects of oxytocin, Physiol Rev, vol.71, pp.331-370, 1991.

R. H. Ring, The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development, Current Pharmaceutical Design, vol.11, issue.2, pp.205-225, 2005.
DOI : 10.2174/1381612053382241

L. Rosso, B. Peteri-brunback, and J. M. Mienville, Putative Physiological Significance of Vasopressin V1a Receptor Activation in Rat Pituicytes, Journal of Neuroendocrinology, vol.16, issue.4, pp.313-318, 2004.
DOI : 10.1111/j.0953-8194.2004.01160.x

J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular cloning: a laboratory manual, 1989.

A. Smith, R. J. Stephen, M. M. Arkley, and N. Mcintosh, Immunoreactive arginine vasopressin in human fetal and neonatal skeletal muscle, Early Human Development, vol.28, issue.3, pp.215-222, 1992.
DOI : 10.1016/0378-3782(92)90168-G

A. Teti, F. Naro, M. Molinaro, and S. Adamo, Transduction of the arginine-vasopressin signal in skeletal myogenic cells, Am J Physiol, vol.265, issue.C34, pp.113-121, 1993.

M. G. Thompson, S. C. Mackie, K. S. Morrison, A. Thom, and R. M. Palmer, Stimulation of protein synthesis and phospholipase D activity by vasopressin and phorbol ester in L6 myoblasts, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1224, issue.2, pp.198-204, 1994.
DOI : 10.1016/0167-4889(94)90191-0

J. Wang and B. Nadal-ginard, Regulation of Cyclins and P34CDC2 Expression during Terminal Differentiation of C2C12 Myocytes, Biochemical and Biophysical Research Communications, vol.206, issue.1, pp.82-88, 1995.
DOI : 10.1006/bbrc.1995.1012

J. J. Watters, M. W. Swank, C. W. Wilkinson, and D. M. Dorsa, Evidence for glucocorticoid regulation of the rat vasopressin V1a receptor gene, Peptides, vol.17, issue.1, pp.67-73, 1996.
DOI : 10.1016/0196-9781(95)02085-3

J. J. Watters, C. W. Wilkinson, and D. M. Dorsa, Glucocorticoid regulation of vasopressin V1a receptors in rat forebrain, Molecular Brain Research, vol.38, issue.2, pp.276-284, 1996.
DOI : 10.1016/0169-328X(95)00345-S